11:46 AM EST - Cipher Pharmaceuticals Inc. : announced its financial and operational results for the three months ended March 31, 2013. Net revenue increased by 82% over Q1 2012 to $3.3 million. EBITDA of $ 1.7 million versus $0.3 million in Q1 2012. Net income was $1.5 million, or $0.06 per share, compared with net income of $0.1 million, or $0.01 per share, in Q1 2012. Cipher Pharmaceuticals Inc.
shares T.DND are trading unchanged at $3.80.
